Overview
GHK-Cu combines a naturally occurring tripeptide with copper. Its scientific attraction lies in tissue remodelling, where both building matrix and regulating matrix breakdown matter1,5.
A cosmetic ingredient’s history does not establish the safety or effectiveness of an injected preparation. This evidence tier is specific to systemic claims for the catalog vial, not a judgment that all topical or laboratory data are absent1,6.
Discovery & copper biology
The historical literature describes GHK as an activity discovered in human albumin and later linked to copper-binding behavior. That observation helped launch work on tissue repair and skin-cell function5.
Copper binding is a biochemical property, not a reason to bypass copper homeostasis. The complex, copper-free GHK and free copper have different experimental roles and cannot be treated as interchangeable interventions1,4,5.
Mechanism of action
Reviews describe effects on collagen, glycosaminoglycans, metalloproteinases and their inhibitors. The proposed benefit is coordinated remodelling rather than indiscriminately producing more collagen1.
Human keratinocyte culture and skin-equivalent experiments found increased integrin expression and proliferation-related markers. The copper-free peptide also showed related activity, so a single simple copper-delivery explanation is incomplete2,4.
- 1Delivers copper where repair needs itGHK binds copper(II) tightly, forming a stable complex that carries the metal into tissue-repair chemistry while limiting free-copper oxidative damage1,5.
- 2Rebuilds the matrixGHK-Cu stimulates collagen and glycosaminoglycan synthesis while regulating the metalloproteinases that clear damaged matrix1.
- 3Renews basal skin cellsIn human keratinocytes and skin equivalents it increased integrin expression and p63-positive, stem-like basal cells, raising the skin’s proliferative potential2,4.
- 4Resets gene expressionGene-expression analyses link GHK to up- or down-regulation of at least 4,000 human genes, a breadth that helps explain its wide-ranging repair effects1.
- Copper coordination
- Collagen turnover
- Matrix metalloproteinases
- Integrin signalling
- Basal keratinocytes
Human evidence & route limits
Reviews summarize topical cosmetic observations involving skin appearance. Those reports differ in exposure and endpoints from a systemic injection, and they do not establish injected hair regrowth or whole-body rejuvenation1,5.
FDA specifically flags injectable GHK-Cu because human safety information is limited and aggregation or impurities may introduce immunogenicity risk. Familiarity with a skin cream does not resolve those issues6.
Faster wound healing1
Reviewed studies report accelerated healing of skin, hair follicles, the gut lining and bone in animal models.
In topical cosmetic studies, GHK-Cu tightened loose skin, improved elasticity, density and firmness, and reduced fine lines and photodamage.
Keratinocytes and skin equivalents showed more integrin expression and more p63-positive, stem-like basal cells.
Stronger ligament grafts3
After ACL reconstruction in 72 rats, GHK-Cu produced stiffer grafts and less knee laxity at 6 weeks.
Repair models
The ACL reconstruction experiment involved 72 rats and examined a local joint intervention. Some laxity and stiffness differences appeared at 6 weeks, but were not sustained at 12 weeks3.
Ultimate graft load, gait and histological scores did not show significant between-group differences in that study. The partial, temporary result should accompany any mention of the favorable early measurements3.
Safety & uncertainty
Injectable safety cannot be inferred from topical tolerability. FDA notes limited human information and potential aggregation-related or impurity-related immunogenicity for injectable GHK-Cu6.
Copper-related disease, hepatic concerns, other copper products and cancer history warrant a provider’s review. The cited mechanistic work does not establish safe chronic systemic exposure or safety in pregnancy and breastfeeding1,5,6.
- FDA flags limited injectable safety data and potential aggregation or impurity-related immunogenicity [6].
- Topical use and systemic injection are not evidence-equivalent.
- Review copper-handling disorders and other copper-containing products with your provider.
- Pregnancy, breastfeeding and long-term systemic effects remain insufficiently characterized.
Supply, storage & administration
The cited skin research includes cultured cells and topical experience; the rat joint experiment is a different route again1,2,3. Confirm the actual prescribed formulation and route for this vial rather than treating cosmetic use as an injection instruction.
The catalog specifies vial content, not a verified final formulation or storage specification. A lyophilized preparation requires the pharmacy-specified compatible diluent; a ready-to-use liquid does not. Follow the dispensing label for refrigeration, light protection and the beyond-use date, and use aseptic technique with a new sterile needle and syringe7. Dosing is set by your provider.
Questions
Does it regrow hair when injected?
The cited evidence does not establish a controlled human injected hair-regrowth outcome.
Why include copper-free GHK research?
It helps distinguish peptide-associated skin-cell effects from the contributions of the copper complex.
GHK-Cu or GLOW?
GLOW adds BPC-157 and TB-500. Component mechanisms do not establish that the combination improves skin or recovery outcomes.
Is a cream equivalent to an injection?
No. Route, exposure and formulation differ, so cosmetic topical observations cannot validate systemic use.
Does more collagen mean better tissue?
Not necessarily. Healthy remodelling depends on synthesis, degradation and organization; the cited biology involves more than synthesis alone.
References
- 1.Review
Pickart L, Vasquez-Soltero JM, Margolina A. BioMed research international, 2015. PMID 26236730
Reviews GHK-Cu’s roles in skin regeneration, from wound healing and matrix remodelling to the regulation of more than 4,000 human genes.
- 2.Cell study
Copper-GHK increases integrin expression and p63 positivity by keratinocytes. (opens in a new tab)
Kang YA, Choi HR, Na JI, et al.. Archives of dermatological research, 2009. PMID 19319546
Human keratinocytes and skin-equivalent models showed increased integrin expression and proliferation-associated markers.
- 3.Animal study
Fu SC, Cheuk YC, Chiu WY, et al.. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2015. PMID 25731775
In 72 rats after ACL reconstruction, GHK-Cu produced stiffer grafts and less knee laxity at 6 weeks; the effect had faded by 12 weeks.
- 4.Cell study
Stem cell recovering effect of copper-free GHK in skin. (opens in a new tab)
Choi HR, Kang YA, Ryoo SJ, et al.. Journal of peptide science : an official publication of the European Peptide Society, 2012. PMID 23019153
Copper-free GHK altered keratinocyte and skin-equivalent proliferation and integrin markers.
- 5.Review
Pickart L, Vasquez-Soltero JM, Margolina A. Oxidative medicine and cellular longevity, 2012. PMID 22666519
Reviews discovery, copper coordination and proposed oxidative-stress biology without proving systemic rejuvenation.
- 6.Guidance / label
U.S. Food and Drug Administration. Regulatory guidance / prescribing information, 2026.
FDA describes limited human safety information and relevant compounding risks for injectable GHK-Cu.
- 7.Guidance / label
Preventing Unsafe Injection Practices (opens in a new tab)
Centers for Disease Control and Prevention. Regulatory guidance / prescribing information, 2024.
Use aseptic technique and a new sterile needle and syringe; opened multi-dose vials generally have a 28-day discard window unless the manufacturer specifies otherwise, never beyond original expiration.
Research summaries are educational and describe published studies, many in animal or cell models. They are not claims that this product treats any condition. Compounded medications are prepared by a licensed 503A pharmacy for individual patients and are not FDA-approved. Statements on this site have not been evaluated by the FDA. Products are dispensed only after review by a licensed provider. This site does not provide medical advice; talk to your provider before starting any therapy.